Literature DB >> 9524953

Survey of Theileria parasite infection in cattle in Taiwan.

C T Wang1, S Kubota, T Kakuda, C C Kuo, T L Hsu, M Onuma.   

Abstract

An survey of Theileria parasite infection in cattle in Taiwan was carried out by polymerase chain reaction (PCR). A total of 491 blood samples, 105 from southern area and 386 from northern area, were collected from bovine in 16 different farms. From northern area, Theileria piroplasms could be seen in only 4 of 105 blood samples microscopically. However, when p32/34 genes (encoding immunodominant piroplasm surface proteins) were amplified by PCR, 15 blood samples were detected positive. They were analyzed by using allele-specific primers of 3 allelic forms of p32/34 and all contained C type of T. sergenti. Four blood samples were found infected with both C and B (T. buffeli) type parasites. Examination of 386 blood samples from southern area of Taiwan did not reveal any Theileria parasite microscopically, as well as by PCR amplification.

Entities:  

Mesh:

Year:  1998        PMID: 9524953     DOI: 10.1292/jvms.60.253

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  3 in total

1.  Development and validation of a quantitative PCR assay using multiplexed hydrolysis probes for detection and quantification of Theileria orientalis isolates and differentiation of clinically relevant subtypes.

Authors:  D R Bogema; A T Deutscher; S Fell; D Collins; G J Eamens; C Jenkins
Journal:  J Clin Microbiol       Date:  2015-01-14       Impact factor: 5.948

2.  Prevalence of Theileria sergenti infection in Korean native cattle by polymerase chain reaction.

Authors:  Kun-Ho Song; Byung-Chan Sang
Journal:  Korean J Parasitol       Date:  2003-09       Impact factor: 1.341

3.  Antigenic diversity of Theileria major piroplasm surface protein gene in Jeju black cattle.

Authors:  Myung-Soon Ko; Kyoung-Kap Lee; Kyu-Kye Hwang; Byung-Sun Kim; Gui-Cheol Choi; Young-Min Yun
Journal:  J Vet Sci       Date:  2008-06       Impact factor: 1.672

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.